Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes

NCT: NCT04338971 · COMPLETED

NCT IDNCT04338971
StatusCOMPLETED
Start Date2017-05-05
Completion2020-10-09

Brief Summary

This study aims to evaluate the impact of the Neurolutions Upper Extremity Rehabilitation System, known as IpsiHand, on improving functional motor control for post-stroke patients with hemiparesis. The Neurolutions System is a brain-computer interface (BCI) comprised of a robotic orthosis, worn on the hand and wrist, and operated by the patient's brain waves which are measured by EEG electrodes. The system also utilizes a tablet interface to provide therapy instructions to the patient.

Frequently Asked Questions

What is Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes?

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes is a clinical trial registered under NCT04338971. Current status: COMPLETED.

What is the status of NCT04338971?

The current status of NCT04338971 (Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes) is: COMPLETED.

When did Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes start?

Ipsihand Device Use in Stroke Patients to Assess Functional Motor Outcomes started on 2017-05-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑